They concluded that the reason for this difference in obese group can possibly be due to the comparison of metformin with diane.[18] To investigate the reduction of CRP in PCOS during metformin treatment, Morin-Papunen et al. showed that CRP significantly decreased after three months and 6 months post treatment respectively compared to the beginning of the study. Here, CRP is linked to polycystic ovary syndrome.